Persistent disruption of autonomic regulation—characterized by prolonged dominance of the sympathetic branch with withdrawal of parasympathetic activity—is proposed to disrupt homeostasis and promote inflammation and oxidative stress. The authors frame this state, termed persistent sympathetic activation, as a physiological mechanism that contributes to a range of chronic conditions, including cardiovascular disease, cancer, and mood disorders. Individuals who experience higher uncertainty, socioeconomic disadvantage, or limited access to care may be at increased risk for sustained autonomic dysfunction. Despite these potential public health consequences, the lived experience of people with conditions marked by autonomic dysfunction has been understudied.
The primary aim was to describe the lived experiences and perspectives of individuals with conditions characterized by autonomic dysfunction, with an emphasis on health needs, perceptions, experiences, and barriers to care among marginalized and vulnerable populations (for example, people who are minoritized, low-income, low-education, rural/medically underserved, or Veterans). The authors sought to identify modifiable targets for interventions and inform future work in this field.
This was a mixed-methods, cross-sectional study. The quantitative component comprised a survey completed by 489 individuals with conditions marked by autonomic dysfunction. A qualitative subset of 45 participants completed semi-structured interviews. The recruitment strategy prioritized inclusion of marginalized populations. The source reports these sample sizes and the focus on underserved groups; additional granular demographic breakdowns and recruitment details are reported in the original article but are not reproduced in full here.
Participants completed a survey that explored symptom burden and experiences seeking and receiving care for conditions and symptoms associated with autonomic dysfunction. A purposive subset participated in semi-structured interviews to capture richer descriptions of lived experience across multiple levels: healthcare system, provider interactions, and individual patient experience. Specific survey instruments, interview guides, and analytic procedures were described in the source article but are not exhaustively detailed in this summary.
At the system level, participants expressed concerns about limited provider availability and a lack of institutional supports for both patients and clinicians managing conditions marked by autonomic dysfunction. These system-level limitations were perceived as barriers to timely diagnosis, coordinated care, and access to appropriate treatments, especially among marginalized groups.
Participants reported a spectrum of provider interactions. Negative experiences commonly involved clinicians who were perceived as dismissive or invalidating of symptoms. Positive experiences were tied to clinicians who listened, believed patients, and provided support. The data emphasize that the patient–provider relationship—including clinician validation—strongly shapes patient experience and subsequent health-seeking behavior.
Respondents identified anxiety, depression, sleep problems, brain fog, and fatigue as the most common and impactful symptoms. Many participants described reducing work hours or leaving employment because of symptom burden. Participants also reported relying on self-directed research and alternative wellness approaches more frequently than on formal provider recommendations when seeking symptom relief.
The authors interpret these multilayered experiences as potentially self-reinforcing. Physiological dysregulation from persistent autonomic imbalance may be amplified by psychosocial factors—such as invalidation by providers, mistrust of the healthcare system, and avoidance of care—creating a feedback loop of distress, reduced physiological regulation, and increased vulnerability. This model links biological and psychosocial contributors to persistent symptoms and poorer function.
The findings underscore the importance of improving system-level access to knowledgeable providers and strengthening patient–provider relationships to validate symptoms and coordinate care. Targeted interventions that address both physiological regulation (for example, treatments aimed at autonomic balance) and psychosocial contributors (for example, clinician training to reduce dismissiveness, expanded access for marginalized groups) may help interrupt the described feedback loop. The study was explicitly intended to inform future intervention development; specific intervention strategies, effectiveness data, and implementation details were not reported in this article.
The source reports that the study data are not publicly available due to ethical restrictions; data can be shared on request with an approved data use agreement and ethical approval. Funding was provided by the Center for Translational Research in Autonomic Health and institutional breakthrough funds; funders did not influence study design, data collection, analysis, or publication. The authors declared no competing interests.
The full manuscript includes methodological details and limitations; this summary is limited to the high-level findings reported in the source. Where the original article provides more granular quantitative subgroup results, instruments, or analytic procedures, those specifics are not reproduced here.
People with conditions marked by autonomic dysfunction describe a multilayered lived experience shaped by symptom burden, employment impacts, the quality of provider interactions, and constraints of the healthcare system. Negative care experiences and limited system supports may compound physiological dysregulation, suggesting that integrated approaches addressing both biological and psychosocial factors are necessary to reduce vulnerability and improve outcomes.